Product Name: Human CD20 Antibody (Ocrelizumab, Research Use)
Catalog Number: NBR-0756
Target Name: CD20
Trade Name: Ocrelizumab
Antibody Drug Description: Ocrelizumab is an intravenously administered, humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD20
Synonyms: Bp35; Bp35; MS4A1; LEU-16
Target Description: B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes.
Ensembl: 
Uniprot: P11836